Cargando…

Cystinuria: An Overview of Diagnosis and Medical Management

Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadiq, Sanober, Cil, Onur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Pediatrics Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317473/
https://www.ncbi.nlm.nih.gov/pubmed/35822468
http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105
_version_ 1784755065411600384
author Sadiq, Sanober
Cil, Onur
author_facet Sadiq, Sanober
Cil, Onur
author_sort Sadiq, Sanober
collection PubMed
description Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid.
format Online
Article
Text
id pubmed-9317473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Pediatrics Association
record_format MEDLINE/PubMed
spelling pubmed-93174732022-08-09 Cystinuria: An Overview of Diagnosis and Medical Management Sadiq, Sanober Cil, Onur Turk Arch Pediatr Review Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid. Turkish Pediatrics Association 2022-07-01 /pmc/articles/PMC9317473/ /pubmed/35822468 http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105 Text en © Copyright 2022 by The Turkish Archives of Pediatrics https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Review
Sadiq, Sanober
Cil, Onur
Cystinuria: An Overview of Diagnosis and Medical Management
title Cystinuria: An Overview of Diagnosis and Medical Management
title_full Cystinuria: An Overview of Diagnosis and Medical Management
title_fullStr Cystinuria: An Overview of Diagnosis and Medical Management
title_full_unstemmed Cystinuria: An Overview of Diagnosis and Medical Management
title_short Cystinuria: An Overview of Diagnosis and Medical Management
title_sort cystinuria: an overview of diagnosis and medical management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317473/
https://www.ncbi.nlm.nih.gov/pubmed/35822468
http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105
work_keys_str_mv AT sadiqsanober cystinuriaanoverviewofdiagnosisandmedicalmanagement
AT cilonur cystinuriaanoverviewofdiagnosisandmedicalmanagement